Cobalt-chrome MULTI-LINK VISION™-stent implantation in diabetics and complex lesions: Results from the DaVinci-Registry

Clinical Research in Cardiology

Volumn 98, Issue 11, 2009, Pages 731-737

  Nef, Holger M ^a   Möllmann, Helge ^a   Weber, Michael ^a   Auch Schwelk, Wolfgang ^b   Bonzel, Tassilo ^c   Varelas, Joanis ^d   Nordt, Thomas K ^e   Schofer, Joachim ^f   Minden, Hans Heinrich ^g   Stumpf, Jürgen ^h   Schneider, Steffen ⁱ   Elsässer, Albrecht ^j   Hamm, Christian W ^a  

^a KERCKHOFF HEART CENTER   (Germany)

^b Kreiskrankenhaus Bergstrasse   (Germany)

^c KLINIKUM FULDA   (Germany)

^d Kardiologische Gemeinschaftspraxis   (Germany)

^e KATHARINENHOSPITAL   (Germany)

^f UNIVERSITY HEART CENTER HAMBURG   (Germany)

^g Abt Kardiologie   (Germany)

^h UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

^j KLINIKUM OLDENBURG   (Germany)

more..

Author keywords

Cobalt chrome stents; Coronary artery disease; Coronary stenting

Indexed keywords

COBALT; COBALT CHROME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BARE METAL STENT; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; INTERNET; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; Q WAVE; REGISTER; RESTENOSIS; REVASCULARIZATION; STENT THROMBOSIS; TREATMENT FAILURE;

EID: 72449139525     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-009-0061-x     Document Type: Article

References (21)

1. A Kastrati J Mehilli J Dirschinger F Dotzer H Schuhlen FJ Neumann M Fleckenstein C Pfafferott M Seyfarth A Schomig 2001 Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial Circulation 103 23 2816 2821 1:STN:280:DC%2BD3MzjsVSksQ%3D%3D
2. R Koster D Vieluf M Kiehn M Sommerauer J Kahler S Baldus T Meinertz CW Hamm 2000 Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis Lancet 356 9245 1895 1897 10.1016/S0140-6736(00)03262-1 1:CAS:528:DC%2BD3cXovFWjsL0%3D
3. P Buszman S Trznadel A Zurakowski K Milewski L Kinasz M Krol M Kondys 2007 Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions Kardiol Pol 65 9 1041 1046 (discussion 1047-1048)
4. DJ Kereiakes M Midei J Hermiller C O'Shaughnessy R Schlofmitz S Yakubov S Fink F Hu N Nishimura M Sievers, et al. 1999 Procedural and late outcomes following MULTI-LINK DUET coronary stent deployment Am J Cardiol 84 12 1385 1390 10.1016/S0002-9149(99)00581-0 1:STN:280:DC%2BD3c%2Fnt1Whtw%3D%3D
5. RA Hill Y Dundar A Bakhai R Dickson T Walley 2004 Drug-eluting stents: an early systematic review to inform policy Eur Heart J 25 11 902 919 10.1016/j.ehj.2004.03.023 1:CAS:528:DC%2BD2cXksVans7s%3D (Pubitemid 38857864)
6. H Mollmann A Elsasser H Nef S Schneider CA Nienaber G Richardt M Weber M Kelm B Levenson T Bonzel, et al. 2008 Treatment of in-stent restenosis with sirolimus-eluting-stents: results from the prospective German Cypher stent registry Clin Res Cardiol 97 7 432 440 10.1007/s00392-008-0646-9
7. EP McFadden E Stabile E Regar E Cheneau AT Ong T Kinnaird WO Suddath NJ Weissman R Torguson KM Kent, et al. 2004 Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 364 9444 1519 1521 10.1016/S0140-6736(04)17275-9 1:CAS:528:DC%2BD2cXovVKrtrs%3D (Pubitemid 39410418)
8. GW Stone JW Moses SG Ellis J Schofer KD Dawkins MC Morice A Colombo E Schampaert E Grube AJ Kirtane, et al. 2007 Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 10 998 1008 10.1056/NEJMoa067193 1:CAS:528:DC%2BD2sXisFKmu7o%3D (Pubitemid 46376800)
9. E Camenzind PG Steg W Wijns 2007 Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern Circulation 115 11 1440 1455 10.1161/CIRCULATIONAHA.106.666800 (discussion 1455)
10. TF Luscher J Steffel FR Eberli M Joner G Nakazawa FC Tanner R Virmani 2007 Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications Circulation 115 8 1051 1058 10.1161/CIRCULATIONAHA.106. 675934 (Pubitemid 46328299)
11. J Carlsson B von Wagenheim R Linder TM Anwari J Qvist I Petersson T Magounakis B Lagerqvist 2007 Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature Clin Res Cardiol 96 2 86 93 10.1007/s00392-007-0464-x 1:STN:280: DC%2BD2s%2Fosl2ntQ%3D%3D (Pubitemid 46233210)
12. L Mauri WH Hsieh JM Massaro KK Ho R D'Agostino DE Cutlip 2007 Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 10 1020 1029 10.1056/NEJMoa067731 1:CAS:528:DC%2BD2sXisFKqtbc%3D (Pubitemid 46376802)
13. C Spaulding J Daemen E Boersma DE Cutlip PW Serruys 2007 A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 10 989 997 10.1056/NEJMoa066633 1:CAS:528:DC%2BD2sXisFKnur4%3D (Pubitemid 46376799)
14. C Briguori C Sarais P Pagnotta F Liistro M Montorfano A Chieffo F Sgura N Corvaja R Albiero G Stankovic, et al. 2002 In-stent restenosis in small coronary arteries: impact of strut thickness J Am Coll Cardiol 40 3 403 409 10.1016/S0735-1097(02)01989-7 (Pubitemid 34833152)
15. J Pache A Kastrati J Mehilli H Schuhlen F Dotzer J Hausleiter M Fleckenstein FJ Neumann U Sattelberger C Schmitt, et al. 2003 Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial J Am Coll Cardiol 41 8 1283 1288 10.1016/S0735-1097(03) 00119-0 (Pubitemid 36438988)
16. P Serruys A Ong JJ Piek F Neumann W van der Giessen M Wiemer A Zeiher E Grube J Haase L Thuesen, et al. 2005 A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: the SPIRIT first trial Eurointervention 1 58 65
17. A Maresta E Varani M Balducelli F Varbella C Lettieri L Uguccioni P Sangiorgio GB Zoccai 2008 Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study) Am J Cardiol 101 11 1560 1566 10.1016/j.amjcard.2008.01.040 1:CAS:528:DC%2BD1cXlvFyms70%3D
18. I Iakovou T Schmidt E Bonizzoni L Ge GM Sangiorgi G Stankovic F Airoldi A Chieffo M Montorfano M Carlino, et al. 2005 Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 17 2126 2130 10.1001/jama.293.17.2126 1:CAS:528:DC%2BD2MXjvFKiu7w%3D (Pubitemid 40617065)
19. SS Brar J Kim SK Brar R Zadegan M Ree IL Liu P Mansukhani V Aharonian R Hyett AY Shen 2008 Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions J Am Coll Cardiol 51 23 2220 2227 10.1016/j.jacc.2008.01.063 1:CAS:528:DC%2BD1cXmvVOgsL0%3D (Pubitemid 351754993)
20. Qiao SB, Hou Q, Xu B, Chen J, Liu HB, Yang YJ, Wu YJ, Yuan JQ, Wu Y, Dai J et al (2006) [Compare drug-eluting stent to bare-metal stent in prognosis on treating diffuse coronary lesions]. Zhonghua Xin Xue Guan Bing Za Zhi 34(6):487-491
21. P Ortolani A Marzocchi C Marrozzini T Palmerini F Saia N Taglieri M Aquilina F Baldazzi S Silenzi RM Cooke, et al. 2007 Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization Catheter Cardiovasc Interv 69 6 790 798 10.1002/ccd.21011 (Pubitemid 46867478)